MaaT Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 50

Employees

  • Stock Symbol
  • MAAT

Stock Symbol

  • Share Price
  • $8.65
  • (As of Friday Closing)

MaaT Pharma General Information

Description

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PAR
Corporate Office
  • 70 Avenue Tony Garnier
  • 69007 Lyon
  • France
+33 04 00 00 00 00

MaaT Pharma Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MaaT Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.65 $8.66 $4.72 - $10.54 $120M 13.9M 2.33K -$1.84

MaaT Pharma Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 64,485 64,485 52,761 137,385
Revenue 2,411 2,411 1,504 1,149
EBITDA (19,958) (19,958) (13,772) (10,132)
Net Income (21,335) (21,335) (14,418) (10,663)
Total Assets 47,456 47,456 47,964 55,954
Total Debt 15,559 15,559 12,185 6,574
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MaaT Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial

MaaT Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial

MaaT Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapi
Drug Discovery
Lyon, France
50 As of 2023
000.00
00000 0000-00-00
00000000 000.00

00000

boris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
0000 000000000
Somerville, MA
00 As of 0000
00000
00000 0000-00-00
00000000 00000

00000

na aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MaaT Pharma Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Finch Therapeutics Formerly VC-backed Somerville, MA 00 00000 00000000 00000
Seres Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
Axial Therapeutics Venture Capital-Backed Woburn, MA 00 00000 0000000000 0 00000
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 000 00000 0000000000 0 00000
Enterome Venture Capital-Backed Paris, France 00 00000 00000000000 00000
You’re viewing 5 of 15 competitors. Get the full list »

MaaT Pharma Patents

MaaT Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4086337-A1 Method of predicting and then producing a mix of microbiota samples Inactive 06-May-2021 00000000 0
AU-2022268615-A1 Method of predicting and then producing a mix of microbiota samples Pending 06-May-2021 00000000
CA-3215683-A1 Method of predicting and then producing a mix of microbiota samples Pending 06-May-2021 00000000
EP-4334434-A1 Method of predicting and then producing a mix of microbiota samples Pending 06-May-2021 00000000
CA-3202036-A1 Method of expanding a complex community of microorganisms Pending 23-Dec-2020 A61K35/74
To view MaaT Pharma’s complete patent history, request access »

MaaT Pharma Executive Team (17)

Name Title Board Seat Contact Info
Herve Affagard Co-Founder, Chief Executive Officer & Board Member
Siân Crouzet Chief Operating Officer & Chief Financial Officer
Philippe Moyen Chief Operating Officer
Carole Schwintner Chief Technology Officer
Gervais Tougas Chief Marketing Officer
You’re viewing 5 of 17 executive team members. Get the full list »

MaaT Pharma Board Members (13)

Name Representing Role Since
Claude Bertrand Ph.D Self Board Member 000 0000
Dorothée Burkel Self Board Member 000 0000
Herve Affagard MaaT Pharma Co-Founder, Chief Executive Officer & Board Member 000 0000
Isabelle de Cremoux Seventure Partners Board Member 000 0000
Jean Volatier Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

MaaT Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MaaT Pharma FAQs

  • When was MaaT Pharma founded?

    MaaT Pharma was founded in 2014.

  • Who is the founder of MaaT Pharma?

    Herve Affagard, Mohamad Mohty MD, Pierre Rimbaud MD, and Pierre Belichard Ph.D are the founders of MaaT Pharma.

  • Who is the CEO of MaaT Pharma?

    Herve Affagard is the CEO of MaaT Pharma.

  • Where is MaaT Pharma headquartered?

    MaaT Pharma is headquartered in Lyon, France.

  • What is the size of MaaT Pharma?

    MaaT Pharma has 50 total employees.

  • What industry is MaaT Pharma in?

    MaaT Pharma’s primary industry is Drug Discovery.

  • Is MaaT Pharma a private or public company?

    MaaT Pharma is a Public company.

  • What is MaaT Pharma’s stock symbol?

    The ticker symbol for MaaT Pharma is MAAT.

  • What is the current stock price of MaaT Pharma?

    As of 24-May-2024 the stock price of MaaT Pharma is $8.65.

  • What is the current market cap of MaaT Pharma?

    The current market capitalization of MaaT Pharma is $120M.

  • What is MaaT Pharma’s current revenue?

    The trailing twelve month revenue for MaaT Pharma is $2.41M.

  • Who are MaaT Pharma’s competitors?

    Finch Therapeutics, Seres Therapeutics, Axial Therapeutics, Vedanta Biosciences, and Enterome are some of the 15 competitors of MaaT Pharma.

  • What is MaaT Pharma’s annual earnings per share (EPS)?

    MaaT Pharma’s EPS for 12 months was -$1.84.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »